BC
UTHR icon

Bridgefront Capital’s United Therapeutics UTHR Stock Holding History

Bridgefront Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$317K Sell
534
-3,941
-88% -$1.96M 0.08% 381
2025
Q4 		$2.18M Buy
4,475
+1,767
+65% +$823K 0.55% 30
2025
Q3 		$1.14M Sell
2,708
-583
-18% -$196K 0.33% 69
2025
Q2 		$946K Buy
+3,291
New +$984K 0.25% 113
2024
Q1 		– Sell
-925
Closed -$203K – 566
2023
Q4 		$203K Buy
+925
New +$213K 0.15% 294
2022
Q4 		– Sell
-1,467
Closed -$307K – 526
2022
Q3 		$307K Buy
+1,467
New +$328K 0.31% 127

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return